Demonstration and characterization of specific binding sites for factor VIII/von Willebrand factor on human platelets.

The presence of specific Factor VIII/von Willebrand factor (FVIII/vWF) binding sites on human platelets has been demonstrated by using 125I-FVIII/vWF and washed human platelets. Binding is ristocetin-dependent and increases in proportion to the concentration of ristocetin from 0.2 to 1 mg/ml. Binding of 125I-FVIII/vWF to platelets can be competitively inhibited by unlabeled human or bovine FVIII/vWF, but not by human thrombin, fibrinogen, alpha 2-macroglobulin, equine collagen, or a lectin of Ricinus communis. Scatchard analysis of binding data indicated that the dissociation constant of FVIII/vWF receptors is 0.45--0.5 nM. There are 31,000 binding sites per platelet at 1 mg/ml of ristocetin concentration. The optimal pH range for binding is from 7.0 to 7.5. At a concentration of 2 mM, EGTA inhibits 86% of the binding; however, 20 mM of Ca++, Mg++, or EDTA have little effect. Binding sites for FVIII/vWF were found only on platelets, and no significant binding was detected with human erythrocytes or polymorphonuclear leukocytes.

[1]  G. Jamieson,et al.  Platelet glycocalicin. Interaction with thrombin and role as thrombin receptor of the platelet surface. , 1978, The Journal of biological chemistry.

[2]  B. Coller.  The effects of ristocetin and von Willebrand factor on platelet electrophoretic mobility. , 1978, The Journal of clinical investigation.

[3]  R. Lefkowitz,et al.  Slowly reversible binding of catecholamine to a nucleotide-sensitive state of the beta-adrenergic receptor. , 1977, The Journal of biological chemistry.

[4]  S. Pizzo,et al.  Relationship of sialic acid to function and in vivo survival of human factor VIII/von Willebrand factor protein. , 1977, The Journal of biological chemistry.

[5]  J. Cazenave,et al.  Properties of Washed Human Platelets , 1977, Thrombosis and Haemostasis.

[6]  R. Grant,et al.  Binding of Factor VIII to Platelets in the Presence of Ristocetin , 1977, British journal of haematology.

[7]  J. Brown,et al.  Preparation and platelet aggregating activity of 125I-labeled ristocetin. , 1977, Analytical biochemistry.

[8]  E. Jaffe,et al.  Immunoinhibition of ristocetin-induced platelet aggregation. , 1977, The Journal of clinical investigation.

[9]  G. Jamieson,et al.  Platelet glycocalicin. I. Orientation of glycoproteins of the human platelet surface. , 1976, The Journal of biological chemistry.

[10]  G. Jamieson,et al.  Platelet glycocalicin: a single receptor for platelet aggregation induced by thrombin or ristocetin. , 1976, Thrombosis research.

[11]  H. Gralnick,et al.  The pH dependence of quantitative ristocetin-induced platelet aggregation: theoretical and practical implications-a new device for maintenance of platelet-rich plasma pH. , 1976, Blood.

[12]  P. McKee,et al.  Studies on human antihemophilic factor. Evidence for a covalently linked subunit structure. , 1976, The Journal of clinical investigation.

[13]  Hoyer Lw.  Von Willebrand's disease. , 1976 .

[14]  D. Green,et al.  Platelet-bound ristocetin aggregation factor in normal subjects and patients with von Willebrand's disease. , 1976, The Journal of laboratory and clinical medicine.

[15]  D. Phillips,et al.  Platelet Membrane Glycoproteins Implicated in Ristocetin-Induced Aggregation , 1975, Thrombosis and Haemostasis.

[16]  E. Kirby,et al.  The interaction of bovine factor VIII with human platelets. , 1975, The Journal of clinical investigation.

[17]  M. Howard.  Inhibition and reversal of ristocetin - induced platelet aggregation. , 1975, Thrombosis research.

[18]  E. Jaffe,et al.  Subcellular platelet factor VIII antigen and von Willebrand factor , 1975, The Journal of experimental medicine.

[19]  H. Kattlove,et al.  Studies on the mechanism of ristocetin-induced platelet aggregation. , 1975, Blood.

[20]  H. Friesen,et al.  Properties of a prolactin receptor from the rabbit mammary gland. , 1974, The Biochemical journal.

[21]  G. Jamieson,et al.  The effects of various lectins on platelet aggregation and release. , 1974, Biochimica et biophysica acta.

[22]  R. Reisfeld,et al.  Protein iodination with solid state lactoperoxidase. , 1974, Biochemistry.

[23]  L. Birnbaumer,et al.  Receptors and acceptors: a necessary distinction in hormone binding studies. , 1974, Advances in cyclic nucleotide research.

[24]  T. Hovig,et al.  Ultrastructural studies on the platelet plug formation in bleeding time wounds from normal individuals and patients with von Willebrand's disease. , 1974, Acta pathologica et microbiologica Scandinavica. Supplement.

[25]  H. Weiss,et al.  Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content. , 1973, The Journal of clinical investigation.

[26]  H. Weiss,et al.  Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII. , 1973, The Journal of clinical investigation.

[27]  S. Pizzo,et al.  The subunit structure of normal and hemophilic factor VIII. , 1973, The Journal of clinical investigation.

[28]  E. Davie,et al.  Isolation and characterization of human Factor VIII (antihemophilic factor). , 1973, The Journal of biological chemistry.

[29]  M. Howard,et al.  Ristocetin: a means of differentiating von Willebrand's disease into two groups. , 1973, Blood.

[30]  D. Phillips.  Effect of trypsin on the exposed polypeptides and glycoproteins in the human platelet membrane. , 1972, Biochemistry.

[31]  K. Weber,et al.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. , 1969, The Journal of biological chemistry.

[32]  Boyd Harshbarger,et al.  Statistical Inference I. , 1964 .

[33]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[34]  G. Scatchard,et al.  THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .